0      0


73562 - Keynote Session III: Mass Spectrometry Enables More Definitive Process & Product Development Towards Well-Characterized Biotherapeutics: A Personal Account


‐ Sep 7, 2023 9:50am

Session Speaker:




Mass Spectrometry Enables More Definitive Process & Product Development Towards Well-Characterized Biotherapeutics: A Personal Account
Jason Rouse, Pfizer, Inc.



Session Chair(s):

You must be logged in and own this session in order to post comments.